A new study, COVID-19 disease blood coagulation. A cluster of scientists in the UK published a major study the other day. Oxford– AstraZeneca vaccine or Pfizer-BioNTech
who received the first doses of the vaccine More than 29 million analyzed data from human beings. They explained that vaccines also rarely improve the risks of exemplary.
COVID-19 vaccines pose less risk from disease
Scientists, thromboembolic events ( blood clots and thrombocytopenia-low platelet count in the blood) examined. Oxford-AstraZeneca vaccine, rarely within 8 to 28 days after the first dose blood clotting eventsand low platelet count found increased risk.
Pfizer-BioNTech in the same time period after the first dose of vaccine, restricted blood flow to the brain caused by blood coagulation and paralysis was also seen to increase the risk. However, these risks were significantly lower than the risks posed by the COVID-19 infection.
Researchers, First dose of Oxford-AstraZeneca vaccine within 28 days of receiving 107 out of 10 million peoplelow platelet assumes from his numbers that he will be hospitalized or die. Against this, coronavirus this number in patients 934 out of 10 million came out to the person.
Within 28 days of the first dose of the Oxford-AstraZeneca vaccine, 66 people per 10 million will be hospitalized or die from blood clots. Not that COVID-19 this in positive persons, 12 thousand 614 out of 10 million person. In addition, Pfizer-BioNTech within 28 days of the first dose of the vaccine, 143 people per 10 million ischemic stroke(stroke) is predicted to be hospitalized or die, while this number is predicted for COVID-19 patients. bin 699 person is out.
However, according to this study, the risks persist for a longer period of time after contracting the coronavirus than after vaccination.
study Oxford University, London School of Hygiene and Tropical Medicine and researchers from several British universities and hospitals. their findings British Medical Journal
They published it on . In this medium, the study authors were independent of the scientists involved in the AstraZeneca vaccine study.